Latest News and Press Releases
Want to stay updated on the latest news?
-
Data from the successful Phase Ia dose escalation study showed that OMX-0407 monotherapy demonstrated a favorable safety profile and signs of anti-tumor activity, with one durable complete response in...
-
Lund, 22 augusti 2024 Dlaboratory Sweden AB (publ) offentliggör idag, den 22 augusti 2024, delårsrapport för perioden 1 april till 30 juni, samt det första halvåret 2024. Den fullständiga...
-
Viktiga punkter 10,5-procentig intäktstillväxt jämfört med kv2 2023 inom våra kärnproduktgrupper, utanför MobileBruttoresultatet i kv2 2024 belastades med 24,3 Mkr i icke-kassaflödespåverkande...
-
New York, United States , Aug. 13, 2024 (GLOBE NEWSWIRE) -- The Global Aircraft Engines Market Size is expected to reach USD 280.7 Billion by 2033, at a CAGR of 6.13% during the forecast period 2023...
-
SAMPO ABP PRESSMEDDELANDE 7 augusti 2024 kl. 9.45 Fortsatt stark utveckling av Sampokoncernen • Sampokoncernens bruttopremieinkomst och förmedlingsintäkter ökade...
-
Aktia Bank AbpBörsmeddelande2.8.2024 kl. 8.00 Aktia Bank Abp:s halvårsrapport 1.1–30.6.2024: Stark resultatförbättring i jämförelse med ifjol och god avkastning på eget kapital Kvartalet i korthet ...
-
NEWARK, Del, July 30, 2024 (GLOBE NEWSWIRE) -- The value of the worldwide argon gas market is set to reach USD 241.3 million by 2024, which is expected to rise to USD 408.4 million through the...
-
No More Deaths: Solidarity Rally for Garvin Yapp in Lead Up to Criminal Prosecution Against Employer
Migrant advocacy groups demand changes to workplace laws in advance of pre-trial of criminal prosecution that will take place on July 25, 2024 What: Solidarity Rally to Demand Justice for Garvin...
-
No More Deaths: Solidarity Rally for Garvin Yapp in Lead Up to Criminal Prosecution Against Employer
TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Justice for Migrant Workers, Injured Workers Action for Justice and the Migrant Farmworker Legal Clinic are organizing a solidarity rally to demand justice...
-
The upsized and oversubscribed Series A financing round will be used to drive the lead development program toward clinical proof-of-concept and to broaden the therapeutic value of the proprietary...